NASDAQ : RXST

RxSight, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 5.05 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 210.05M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

RxSight, Inc. (RXST) reported revenue of 127.58M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue127.58M134.48M139.93M89.08M49.01M22.59M
Cost of Revenue28.71M31.47M40.98M35.31M27.68M18.08M
Gross Profit98.88M103.01M98.94M53.77M21.33M4.52M
Selling, General & Admin117.32M112.66M101.52M74.90M58.99M33.10M
Research & Development36.67M38.54M34.28M28.95M25.66M24.20M
Operating Expenses153.99M151.20M135.80M103.85M84.65M57.30M
Operating Income-55.11M-48.19M-36.86M-50.09M-63.32M-52.79M
Interest Expense-14.00K-19.00K-21.00K-3.31M-4.95M-3.68M
Interest & Investment Income8.29M9.33M9.47M6.57M1.52M54.00K
Other Non Operating Income (Expenses)7.74M
EBT Excluding Unusual Items-46.84M-38.88M-27.41M-46.82M-66.75M-48.68M
Other Unusual Items-1.77M
Pretax Income-46.84M-38.88M-27.41M-48.59M-66.75M-48.68M
Income Tax Expense110.00K66.00K50.00K20.00K9.00K8.00K
Earnings From Continuing Operations-38.94M-27.45M-48.61M-66.76M-48.69M
Net Income-46.95M-38.94M-27.45M-48.61M-66.76M-48.69M
Net Income to Common-46.95M-38.94M-27.45M-48.61M-66.76M-48.69M
Shares Outstanding (Basic)41.24M40.85M38.87M34.46M27.66M13.63M
Shares Outstanding (Diluted)41.24M40.85M38.87M34.46M27.66M13.63M
EPS (Basic)-1.14-0.95-0.71-1.41-2.41-3.57
EPS (Diluted)-1.14-0.95-0.71-1.41-2.41-3.57
Free Cash Flow-27.16M-19.34M-22.39M-46.41M-61.24M-46.65M
Free Cash Flow Per Share-0.66-0.47-0.58-1.35-2.21-3.42
Gross Margin77.50%76.60%70.71%60.36%43.52%19.99%
Operating Margin-43.20%-35.84%-26.34%-56.23%-129.21%-233.64%
Profit Margin-36.80%-28.96%-19.62%-54.57%-136.22%-215.50%
Free Cash Flow Margin-21.29%-14.38%-16.00%-52.10%-124.97%-206.47%
EBITDA-51.58M-44.92M-33.28M-46.01M-59.43M-48.81M
EBITDA Margin-40.42%-33.41%-23.79%-51.65%-121.28%-216.05%
D&A For EBITDA3.54M3.27M3.58M4.08M3.88M3.98M
EBIT-55.11M-48.19M-36.86M-50.09M-63.32M-52.79M
EBIT Margin-43.20%-35.84%-26.34%-56.23%-129.21%-233.64%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents13.35M19.95M16.71M9.69M11.83M24.36M
Short-Term Investments195.45M208.18M220.52M117.49M93.97M134.97M
Cash & Short-Term Investments208.80M228.13M237.22M127.18M105.80M159.33M
Receivables78.52M23.38M30.05M20.28M10.96M4.86M
Inventory37.12M31.56M22.01M17.42M14.84M8.03M
Prepaid Expenses2.96M4.39M4.54M3.52M2.96M4.07M
Total Current Assets327.40M287.46M293.82M168.41M134.56M176.29M
Property, Plant & Equipment23.53M23.02M23.63M13.29M14.08M15.50M
Other Long-Term Assets1.77M1.34M1.11M858.00K1.53M925.00K
Total Assets352.70M311.81M318.56M182.55M150.16M192.72M
Accounts Payable6.34M5.30M4.54M3.86M2.60M1.69M
Accrued Expenses15.55M10.49M14.46M10.64M8.99M6.24M
Current Portion of Leases1.66M1.16M974.00K1.80M1.97M1.53M
Current Unearned Revenue6.88M3.60M3.11M2.04M1.35M618.00K
Other Current Liabilities50.00M5.71M2.79M2.56M2.33M1.01M
Total Current Liabilities80.44M26.25M25.88M20.90M17.24M11.08M
Long-Term Debt40.17M39.76M
Long-Term Leases8.92M9.88M11.32M1.21M2.86M3.64M
Other Long-Term Liabilities127.00K74.00K
Total Liabilities89.36M36.13M37.33M22.19M60.26M54.48M
Common Stock41.00K41.00K40.00K36.00K28.00K27.00K
Additional Paid-In Capital952.38M936.63M903.13M754.97M636.00M617.51M
Retained Earnings-689.02M-661.04M-622.10M-594.64M-546.03M-479.28M
Comprehensive Income & Other-59.00K53.00K166.00K-5.00K-95.00K-20.00K
Total Common Equity263.34M275.68M281.24M160.36M89.90M138.24M
Shareholders' Equity263.34M275.68M281.24M160.36M89.90M138.24M
Total Liabilities & Equity352.70M311.81M318.56M182.55M150.16M192.72M
Total Debt10.58M11.04M12.30M3.01M44.99M44.93M
Net Cash (Debt)198.22M217.09M224.93M124.17M60.81M114.40M
Net Cash Per Share4.815.315.793.602.208.40
Filing Date Shares Outstanding41.59M41.27M40.49M36.99M33.78M27.42M
Total Common Shares Outstanding41.59M41.24M40.43M36.14M28.27M27.37M
Working Capital246.95M261.21M267.95M147.50M117.32M165.22M
Book Value Per Share6.336.686.964.443.185.05
Tangible Book Value263.34M275.68M281.24M160.36M89.90M138.24M
Tangible Book Value Per Share6.336.686.964.443.185.05
Machinery22.66M21.93M19.50M17.29M16.08M
Construction In Progress1.72M1.54M2.33M1.33M1.12M
Leasehold Improvements15.17M14.25M11.55M11.21M10.33M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-46.95M-38.94M-27.45M-48.61M-66.76M-48.69M
Depreciation & Amortization3.54M3.27M3.58M4.08M4.02M3.99M
Other Amortization287.00K552.00K493.00K
Loss (Gain) From Sale of Investments-7.58M-8.52M-8.98M-6.12M-1.41M-30.00K
Stock-Based Compensation31.34M31.61M24.64M15.75M11.40M7.58M
Provision & Write-off of Bad Debts206.00K32.00K34.00K
Other Operating Activities1.86M1.93M404.00K1.93M752.00K-5.37M
Change in Accounts Receivable9.36M6.66M-9.80M-9.32M-6.09M-2.00M
Change in Inventory-13.91M-11.48M-4.99M-2.75M-7.55M-2.11M
Change in Accounts Payable3.06M627.00K946.00K1.25M635.00K555.00K
Change in Other Net Operating Assets-7.15M-692.00K4.69M1.92M5.60M874.00K
Operating Cash Flow-22.73M-15.51M-16.95M-41.59M-58.85M-44.71M
Capital Expenditures-4.43M-3.83M-5.44M-4.81M-2.39M-1.94M
Investment in Securities-685.00K20.72M-93.87M-17.32M42.34M-79.97M
Investing Cash Flow-5.12M16.89M-99.31M-22.13M39.95M-81.91M
Long-Term Debt Issued20.00M15.00M
Long-Term Debt Repaid-26.00K-61.00K-60.15M-121.00K-27.00K
Net Debt Issued (Repaid)-24.00K-26.00K-61.00K-40.15M-121.00K14.97M
Issuance of Common Stock2.00M3.95M128.92M105.96M7.83M121.71M
Repurchase of Common Stock-1.12M-2.06M-4.77M-1.42M-643.00K
Other Financing Activities-768.00K-2.86M-732.00K-132.00K
Financing Cash Flow859.00K1.86M123.32M61.52M6.33M137.34M
Foreign Exchange Rate Adjustments-11.00K3.00K-9.00K6.00K-9.00K-10.00K
Miscellaneous Cash Flow Adjustments-1.00K-1.00K
Net Cash Flow-27.00M3.24M7.05M-2.19M-12.58M10.72M
Free Cash Flow-27.16M-19.34M-22.39M-46.41M-61.24M-46.65M
Free Cash Flow Margin-21.29%-14.38%-16.00%-52.10%-124.97%-206.47%
Free Cash Flow Per Share-0.66-0.47-0.58-1.35-2.21-3.42
Levered Free Cash Flow-6.73M-1.63M-9.85M-26.71M-35.16M-30.39M
Unlevered Free Cash Flow-6.72M-1.61M-9.84M-24.93M-32.62M-28.58M
Cash Interest Paid3.46M4.26M3.19M
Cash Income Tax Paid132.00K58.00K24.00K8.00K3.00K20.00K
Change in Working Capital-5.14M-4.89M-9.16M-8.91M-7.41M-2.68M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization202.14M428.44M1.39B1.45B351.23M307.73M
Enterprise Value3.92M212.48M1.16B1.32B283.73M184.61M
Last Close Price4.8710.4234.3840.3212.6711.25
PS Ratio1.593.199.9016.237.1713.62
PB Ratio0.771.554.939.023.912.23
P/TBV Ratio0.771.554.939.023.912.23
EV/Sales Ratio0.031.588.2914.795.798.17
Debt / Equity Ratio0.040.040.040.020.500.33
Net Debt / Equity Ratio-0.75-0.79-0.80-0.77-0.68-0.83
Net Debt / EBITDA Ratio3.844.836.762.701.022.34
Net Debt / FCF Ratio7.3011.2210.052.680.992.45
Asset Turnover0.390.430.560.540.290.15
Inventory Turnover0.921.182.082.192.422.21
Quick Ratio3.579.5810.337.056.7714.82
Current Ratio4.0710.9511.368.067.8115.91
Return on Equity (ROE)-17.34%-13.98%-12.43%-38.84%-58.52%-159.76%
Return on Assets (ROA)-10.41%-9.56%-9.19%-18.82%-23.08%-22.49%
Return on Invested Capital (ROIC)-87.93%-83.88%-79.69%-153.43%-239.23%-93.50%
Return on Capital Employed (ROCE)-20.20%-16.90%-12.60%-31.00%-47.60%-29.10%
Earnings Yield-23.43%-9.09%-1.98%-3.36%-19.01%-15.82%
FCF Yield-13.41%-4.51%-1.62%-3.21%-17.44%-15.16%
Buyback Yield / Dilution-2.18%-5.10%-12.81%-24.56%-103.02%-146.28%